Arnold S Rapoport, MD in Adirondack, NY - Otolaryngology

Arnold S Rapoport, MD is a Otolaryngology physician based in Adirondack, New York. Arnold S Rapoport is licensed to practice in New York (license number 097940) and his current practice location is 49 Sugar Hill Way, Adirondack, New York. He can be reached at his office (for appointments etc.) via phone at (518) 532-9986.

NPI number for Arnold S Rapoport is 1750794814 and his current mailing address is Po Box 191, Adirondack, New York. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1750794814.

Contact Information

	Arnold S Rapoport, MD
	49 Sugar Hill Way, Adirondack, NY 12808-0191
	(518) 532-9986
	Not Available

Physician's Profile

Full Name	Arnold S Rapoport
Gender	Male
Speciality	Otolaryngology
Location	49 Sugar Hill Way, Adirondack, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1750794814
Provider Enumeration Date: 06/06/2014
Last Update Date: 06/06/2014

Medical Identifiers

Medical identifiers for Arnold S Rapoport such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1750794814	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	097940 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Arnold S Rapoport is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Arnold S Rapoport, MD Po Box 191, Adirondack, NY 12808-0191 Ph: (518) 532-9986	Arnold S Rapoport, MD 49 Sugar Hill Way, Adirondack, NY 12808-0191 Ph: (518) 532-9986

News Archive

Researchers develop evidence-based model that can predict amount of nicotine released from e-cigarette

Virginia Commonwealth University Massey Cancer Center researchers at the VCU Center for the Study of Tobacco Products (CSTP) have developed the first ever, evidence-based model that can predict with up to 90 percent accuracy the amount of nicotine emitted by an electronic cigarette (e-cigarette).

Study finds fewer new cases of HCV in HIV-negative men who have sex with PrEP-using men

Data from a new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found fewer new cases of hepatitis C infection (commonly called HCV), despite very high rates of other sexually-transmitted infections, in HIV-negative men who have sex with men who take pre-exposure prophylaxis (PrEP) treatments.

Diagnosis of prions in patients should utilize novel strategy, conformation-dependent immunoassay

A technique for detecting prions in tissue, developed in recent years by UCSF scientists, is significantly more sensitive than the diagnostic procedures currently used to detect the lethal particles in samples of brain tissue from patients, according to a study performed by a UCSF team.

Dr. Reddy reports $257 million revenue from global generics in first-quarter fiscal 2011

Dr. Reddy's Laboratories Ltd. today announced its unaudited financial results for the quarter ended June 30, 2010 under International Financial Reporting Standards (IFRS).

Blue light can illuminate areas affected by diabetic retinopathy

Just as bright light can illuminate the depths of a darkened room, researchers in Japan have found that blue light can be used to probe the depths of the eye and uncover areas affected by diabetic retinopathy (DR), a leading cause of blindness.

Arnold S Rapoport, MD - Otolaryngology in Adirondack, NY